Carcinoma, Renal CellKidney NeoplasmsPrognosisGene TherapyImmunotherapyThe Immunotherapy and Gene Therapy meeting of the Academy of Medical Sciences reviewed the state-of-the-art and translational prospects for therapeutic interventions aimed at killing tumor cells, correcting genetic defects and developing ...
Vaccine and gene therapy of renal cell carcinoma Immunotherapy, ActiveThe concept of tumor vaccines is not new. However, advances in gene transfer technology, tumor immunology, molecular biology, and ... BJ Gitlitz,AS Belldegrun,RA Figlin - 《Semin Urol Oncol》 被引量: 59发表: 2001年 Gene...
Cell, Tissue and Gene TherapySection edited by David Stroncek This section aims to improve communication between basic and clinical research related to cell, tissue and gene therapies. Effective clinical therapies require efficient translation of research between the bench and bedside to allow the ...
gene replacement, gene silencing, and gene editing. It represents a distinct therapeutic approach from traditional medications and introduces novel strategies for genetic disorders. Over the past two decades, significant advancements have been made in the field of gene therapy, leading to the approval...
ADOPTIVE IMMUNOTHERAPY AND CAR-T CELLS: A REVOLUTIONARY CELL/GENE THERAPY TO TREAT CANCER 来自 掌桥科研 喜欢 0 阅读量: 91 公开/公告号: 10.1142/9781786346889_0021 发明人: D Scherman 被引量: 30 摘要: The following sections are included:IntroductionThe Immunological SynapseTCR Structure and ...
Corning provides a broad range of cell culture systems, equipment, and solutions for advanced cell and gene therapy applications, and regulatory compliance.
A cooperative nano-CRISPR scaffold potentiates immunotherapy via activation of tumour-intrinsic pyroptosis Delivery of immune therapy drugs to tumours might be hampered by their limited bioavailability and the difficulty of targeting complex exogenous compounds. Here authors trigger immunologic cell death, vi...
Advanced cancer has been treated mostly by chemotherapy and targeted therapy using small molecule inhibitors. After intensive research on the potential of immunotherapy over the past decade, the first immune checkpoint inhibitor (ICI) was approved in 2011, which targeted cytotoxic lymphocyte antigen 42....
Immunotherapies have become the backbone of cancer treatment. Among them, chimeric antigen receptor (CAR) T cells have demonstrated great success in the treatment of hematological malignancies. However, CAR T therapy against solid tumors is less effectiv
Methods of gene therapy Gene therapy implies an approach that aims to modify, delete, or replace abnormal gene(s) at a target cell. Such target cells may be malignant primary or metastatic nodules, circulating tumor cells or dormant stem cells, and specific cells such as T-cell lymphocytes or...